IFI44 抗体 (AA 182-435)
Quick Overview for IFI44 抗体 (AA 182-435) (ABIN1817268)
抗原
See all IFI44 抗体适用
宿主
克隆类型
标记
应用范围
- 
    - 
                                            抗原表位
- AA 182-435
- 
                                            特异性
- Human IFI44 / p44.
- 
                                            纯化方法
- Affinity purified
- 
                                            免疫原
- 
                        A recombinant human IFI44 protein 182-435aa (BC022870).
 Type of Immunogen: Recombinant protein
 
- 
                                            
- 
    
- 
    - 
                                            应用备注
- Approved: ELISA (1:20000 - 1:80000), IHC (1:100 - 1:500), WB (1:1000 - 1:2000)
- 
                                            说明
- 
                        Target Species of Antibody: Human 
- 
                                            限制
- 仅限研究用
 
- 
                                            
- 
    - 
                                            状态
- Liquid
- 
                                            浓度
- Lot specific
- 
                                            缓冲液
- PBS, pH 7.4, 0.02 % sodium azide
- 
                                            储存液
- Sodium azide
- 
                                            注意事项
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- 
                                            储存条件
- -20 °C
- 
                                            储存方法
- Store at -20°C for up to 1 year.
- 
                                            有效期
- 12 months
 
- 
                                            
- 
    - IFI44 (Interferon-Induced Protein 44 (IFI44))
- 
                                            别名
- IFI44 / p44
- 
                                            背景
- 
                        Name/Gene ID: IFI44
 Synonyms: IFI44, p44, MTAP44, Interferon-induced protein 44
- 
                                            基因ID
- 10561
- 
                                            UniProt
- Q8TCB0
 抗原
- 
                    
 
                                     
                                     
                                    